AU2190400A - Inhibitors of beta-lactamases and uses therefor - Google Patents
Inhibitors of beta-lactamases and uses thereforInfo
- Publication number
- AU2190400A AU2190400A AU21904/00A AU2190400A AU2190400A AU 2190400 A AU2190400 A AU 2190400A AU 21904/00 A AU21904/00 A AU 21904/00A AU 2190400 A AU2190400 A AU 2190400A AU 2190400 A AU2190400 A AU 2190400A
- Authority
- AU
- Australia
- Prior art keywords
- lactamases
- inhibitors
- beta
- uses therefor
- therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/70—Nitro radicals
- C07D307/71—Nitro radicals attached in position 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11245098P | 1998-12-16 | 1998-12-16 | |
US60112450 | 1998-12-16 | ||
PCT/US1999/029956 WO2000035905A1 (en) | 1998-12-16 | 1999-12-16 | INHIBITORS OF β-LACTAMASES AND USES THEREFOR |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2190400A true AU2190400A (en) | 2000-07-03 |
Family
ID=22343973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU21904/00A Abandoned AU2190400A (en) | 1998-12-16 | 1999-12-16 | Inhibitors of beta-lactamases and uses therefor |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2190400A (en) |
WO (1) | WO2000035905A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7112572B2 (en) | 2002-09-09 | 2006-09-26 | Trigen Limited | Multivalent metal salts of boronic acids |
PT2603514T (en) | 2010-08-10 | 2018-11-09 | Rempex Pharmaceuticals Inc | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
US9012491B2 (en) | 2011-08-31 | 2015-04-21 | Rempex Pharmaceuticals, Inc. | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
US9156858B2 (en) | 2012-05-23 | 2015-10-13 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US10561675B2 (en) | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
AU2014204045B2 (en) | 2013-01-04 | 2018-10-18 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US9101638B2 (en) | 2013-01-04 | 2015-08-11 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CA2894892A1 (en) | 2013-01-04 | 2014-07-10 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US9241947B2 (en) | 2013-01-04 | 2016-01-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
LT3604316T (en) | 2014-05-05 | 2024-02-26 | Melinta Therapeutics, Inc. | Synthesis of boronate salts |
WO2015171398A1 (en) | 2014-05-05 | 2015-11-12 | Rempex Pharmaceuticals, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
WO2015179308A1 (en) | 2014-05-19 | 2015-11-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
WO2016003929A1 (en) | 2014-07-01 | 2016-01-07 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
WO2016081297A1 (en) | 2014-11-18 | 2016-05-26 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
US20180051041A1 (en) | 2015-03-17 | 2018-02-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
DK3478693T3 (en) | 2016-06-30 | 2021-09-20 | Qpex Biopharma Inc | BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF |
US11286270B2 (en) | 2017-10-11 | 2022-03-29 | Qpex Biopharma, Inc. | Boronic acid derivatives and synthesis thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5482974A (en) * | 1994-03-08 | 1996-01-09 | Monsanto Company | Selected fungicides for the control of take-all disease of plants |
US6020531A (en) * | 1996-07-24 | 2000-02-01 | Teikoku Hormone Mfg. Co., Ltd. | Process for the preparation of 2,6-disubstituted benzothiophene compounds |
-
1999
- 1999-12-16 AU AU21904/00A patent/AU2190400A/en not_active Abandoned
- 1999-12-16 WO PCT/US1999/029956 patent/WO2000035905A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000035905A1 (en) | 2000-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8140898A (en) | Inhibitors of beta-lactamases and uses therefor | |
AU4429799A (en) | Inhibitors of p38 | |
AU4231197A (en) | Hppd gene and inhibitors | |
AU3109099A (en) | Allosteric inhibitors and activators of pyruvate kinase | |
AU3665199A (en) | Inhibitors of impdh enzyme | |
AU3972697A (en) | Inhibitors of cysteine protease | |
AU1271297A (en) | Inhibitor of ceramidase | |
AU3124300A (en) | Inhibitors of beta-lactamases and uses therefor | |
PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
AU1536799A (en) | Bishydroxyureas as inhibitors of the 5-lipoxygenase | |
AU2190400A (en) | Inhibitors of beta-lactamases and uses therefor | |
AU5619400A (en) | Statine-derived tetrapeptide inhibitors of beta-secretase | |
AU3107795A (en) | Inhibitors of the benzamidine type | |
AU9059798A (en) | Urokinase inhibitors | |
AU5599598A (en) | Inhibitors of glycosyltransferases | |
AU5463099A (en) | Inhibitors of redox signaling and methods of using same | |
HUP0101640A3 (en) | Certain thoil inhibitors of endothelin-converting enzyme | |
AU1969800A (en) | Combination of active agents | |
AU2277597A (en) | New inhibitors of sh2-mediated processes | |
AU9624398A (en) | Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors | |
AU1766997A (en) | Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors | |
AU4501199A (en) | 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors | |
AU1287100A (en) | Peptide inhibitor of browman-birk type | |
AU2849399A (en) | Monobactam enzyme inhibitors | |
AU2333099A (en) | Aryloxyanilides and related compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |